Literature DB >> 16159062

Intra-arterial thrombolysis of a distal internal carotid artery occlusion in an adolescent.

Eric C Bourekas1, Andrew P Slivka, Marcel J Casavant.   

Abstract

INTRODUCTION: This article describes the first reported case of an adolescent being treated with intra-arterial urokinase for a distal internal carotid artery occlusion.
METHODS: A 15-year-old male presenting with an acute ischemic stroke caused by a distal internal carotid artery occlusion was treated with intra-arterial urokinase at 5 hours and 45 minutes after symptom onset.
RESULTS: The artery completely recanalized, and the patient improved significantly from an admission National Institutes of Health Stroke Scale (NIHSS) score of 28 to a NIHSS score of 8 at a 2.5-month follow-up, despite an asymptomatic intraparenchymal hemorrhage.
CONCLUSION: This article reviews the only two reported cases of intravenous thrombolysis and three cases of intra-arterial thrombolysis in children with ischemic stroke and suggests that thrombolytic therapy should be considered a treatment option in selected pediatric patients with stroke, especially in adolescents who are generally treated as young adults.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159062     DOI: 10.1385/NCC:2:2:179

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  15 in total

1.  Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7: the era of reperfusion: section 2: acute stroke. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation.

Authors: 
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

Review 2.  Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years.

Authors:  W Zenz; F Arlt; S Sodia; A Berghold
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

3.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors:  W M Clark; S Wissman; G W Albers; J H Jhamandas; K P Madden; S Hamilton
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

4.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

5.  Time lag to diagnosis of stroke in children.

Authors:  Lidia V Gabis; Ravi Yangala; Nicholas J Lenn
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

6.  Stroke in children: the coexistence of multiple risk factors predicts poor outcome.

Authors:  S Lanthier; L Carmant; M David; A Larbrisseau; G de Veber
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl.

Authors:  Meredith R Golomb; Mubeen Rafay; Derek Armstrong; Patricia Massicotte; Rosalind Curtis; Selina Hune; Gabrielle A deVeber
Journal:  J Child Neurol       Date:  2003-06       Impact factor: 1.987

9.  Successful endovascular therapy for acute basilar thrombosis in an adolescent.

Authors:  Adam Kirton; John H Wong; Jean Mah; B Catherine Ross; James Kennedy; Katherine Bell; Michael D Hill
Journal:  Pediatrics       Date:  2003-09       Impact factor: 7.124

10.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

View more
  1 in total

1.  Hyperacute therapies for childhood stroke: a case report and review of the literature.

Authors:  Jose Irazuzta; Kevin J Sullivan
Journal:  Neurol Res Int       Date:  2010-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.